1. |
Spinale FG. Myocardial matrix remodeling and the matrix metalloproteinases:influence on cardiac form and function. Physiol Rev, 2007, 87 (4):1285-1342.
|
2. |
Zhang Hao, Zhu Shen-jun, Wang De, et al. Intramyocardial injection of tannic acid attenuates postinfarction remodeling:a novel approach to stabilize the breaking extracellular matrix. J Thorac Cardiovasc Surg, 2009, 137 (1):216-222.
|
3. |
Jain RA. The manufacturing techniques of various drug loaded biodegradable poly (lactide-co-glycolide) (PLGA) devices. Biomaterials, 2000, 21 (23):2475-2490.
|
4. |
劉偉強, 陳玉成, 熊素彬, 等. 心肌內注射17 β-雌二醇納米粒的促血管生成效應及相關機制研究. 心臟雜志, 2008, 20 (1):17-20..
|
5. |
D′Souza SS, DeLuca PP. Methods to assess in vitro drug release from injectable polymeric particulate systems. Pharm Res, 2006, 23 (3):460-474.
|
6. |
朱沈軍, 張浩, 胡盛壽, 等. 微囊化重組CHO細胞移植促進大鼠心肌梗死后血管新生的實驗研究. 中國胸心血管外科臨床雜志,2008, 15 (1):38-43..
|
7. |
周騏,周建業,胡盛壽,等. 大網膜聯合組織工程心肌移植改善心肌梗死后大鼠心功能. 中國胸心血管外科臨床雜志,2008,15 (6):432-437..
|
8. |
張浩, 侯邁, 胡盛壽. 小鼠心肌梗死模型的建立和無創超聲評價. 中國微創外科雜志, 2007, 7 (11):1111-1112..
|
9. |
Rhaleb NE, Peng H, Yang XP, et al. Long-term effect of N-acetyl-seryl-aspartyl-lysyl-proline on left ventricular collagen deposition in rats with 2-kidney, 1-clip hypertension. Circulation, 2001, 103 (25):3136-3141.
|
10. |
Stegemann H, Stalder K. Determination of hydroxyproline. Clin Chim Acta, 1967, 18 (2):267-273.
|
11. |
魏海峰, 魏雁虹, 李蘊潛, 等. 單寧酸對糖尿病大鼠腎組織炎癥因子表達的抑制作用. 吉林大學學報:醫學版, 2011, 37 (3):393-397.
|
12. |
魏海峰, 魏雁虹, 李相軍, 等. 單寧酸對糖尿病大鼠抗氧化能力及體外蛋白質非酶糖基化作用的影響. 中國實驗診斷學, 2011, 15 (6):977-979.
|
13. |
Jastrzebska M, Zalewska-Rejdak J, Wrzalik R, et al. Tannic acid-stabilized pericardium tissue:IR spectroscopy, atomic force microscopy, and dielectric spectroscopy investigations. J Biomed Mater Res A, 2006, 78 (1):148-156.
|
14. |
Isenburg JC, Simionescu DT, Starcher BC, et al. Elastin stabilization for treatment of abdominal aortic aneurysms. Circulation, 2007, 115 (13):1729-1737.
|
15. |
Isenburg JC, Simionescu DT, Vyavahare NR. Tannic acid treatment enhances biostability and reduces calcification of glutaraldehyde fixed aortic wall. Biomaterials, 2005, 26 (11):1237-1245.
|
16. |
Jain R, Shah NH, Malick AW, et al. Controlled drug delivery by biodegradable poly (ester) devices:different preparative approaches. Drug Dev Ind Pharm, 1998, 24 (8):703-727.
|
17. |
Athanasiou KA, Niederauer GG, Agrawal CM. Sterilization, toxicity, biocompatibility and clinical applications of polylactic acid/polyglycolic acid copolymers. Biomaterials, 1996, 17 (2):93-102.
|
18. |
連鋒, 朱洪生, 張有榮, 等.bFGF緩釋微膠囊誘導缺血心肌血管新生的實驗研究.中華胸心血管外科雜志, 2000, 16 (6):352-354..
|
19. |
Kumari A, Yadav SK, Yadav SC. Biodegradable polymeric nanoparticles based drug delivery systems. Colloids Surf B Biointerfaces, 2010, 75 (1):1-18.
|
20. |
陳國廣, 周本謙, 李學明, 等. 5-氟尿嘧啶PLGA納米粒的制備及其體內外釋藥研究. 中國藥科大學學報, 2006, 37 (5):423-427.
|
21. |
Vanhoutte D, Schellings M, Pinto Y, et al. Relevance of matrix metalloproteinases and their inhibitors after myocardial infarction:a temporal and spatial window. Cardiovasc Res, 2006, 69 (3):604-613.
|
22. |
Peterson JT, Li H, Dillon L, et al. Evolution of matrix metalloprotease and tissue inhibitor expression during heart failure progression in the infarcted rat. Cardiovasc Res, 2000, 46 (2):307-315.
|
23. |
Delahaye P, Verzele M. Analysis of gallic, digallic and trigallic acids in tannic acids by high-performance liquid chromatography. J Chromatogr A, 1983, 265:363-367.
|
24. |
Kennedy JA, Waterhouse AL. Analysis of pigmented high-molecular mass grape phenolics using ion-pair, normal-phase high-performance liquid chromatography. J Chromatogr A, 2000, 866 (1):25-34.
|
25. |
Romani A, Ieri F, Turchetti B, et al. Analysis of condensed and hydrolysable tannins from commercial plant extracts. J Pharm Biomed Anal, 2006, 41 (2):415-420.
|